These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 23150626

  • 1. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
    Aifa A, Gueudry J, Portmann A, Delcampe A, Muraine M.
    Invest Ophthalmol Vis Sci; 2012 Dec 13; 53(13):8181-5. PubMed ID: 23150626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.
    Arvola RP, Robciuc A, Holopainen JM.
    Cornea; 2016 Apr 13; 35(4):451-5. PubMed ID: 26845313
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.
    Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J.
    Ophthalmology; 2007 Sep 13; 114(9):1637-42. PubMed ID: 17382396
    [Abstract] [Full Text] [Related]

  • 7. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration.
    Tan MH, Bryars J, Moore J.
    Cornea; 2006 Apr 13; 25(3):352-5. PubMed ID: 16633039
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Autologous serum application in the treatment of neurotrophic keratopathy.
    Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K.
    Ophthalmology; 2004 Jun 13; 111(6):1115-20. PubMed ID: 15177961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis.
    Turkoglu E, Celik E, Alagoz G.
    Semin Ophthalmol; 2014 May 13; 29(3):119-26. PubMed ID: 23758337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.
    Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, Foster CS, Affeldt J, Seedor JA, Afshari NA, Chao W, Allegretti M, Mantelli F, Dana R.
    Ophthalmology; 2020 Jan 13; 127(1):14-26. PubMed ID: 31585826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS.
    Cornea; 2008 Sep 13; 27(8):859-61. PubMed ID: 18724142
    [Abstract] [Full Text] [Related]

  • 16. [Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
    Muraine M, Descargues G, Franck O, Villeroy F, Toubeau D, Menguy E, Martin J, Brasseur G.
    J Fr Ophtalmol; 2001 Oct 13; 24(8):798-812. PubMed ID: 11894530
    [Abstract] [Full Text] [Related]

  • 17. Effect of a New Matrix Therapy Agent in Persistent Epithelial Defects After Bacterial Keratitis Treated With Topical Fortified Antibiotics.
    Chappelet MA, Bernheim D, Chiquet C, Aptel F.
    Cornea; 2017 Sep 13; 36(9):1061-1068. PubMed ID: 28691943
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS, Rivas L, García-Lozano I, Murube J.
    Ophthalmology; 2008 Feb 13; 115(2):262-7. PubMed ID: 17675158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.